New mRNA-based malaria vaccine shows promise in preclinical trials
Trans-Tasman research collaborators from Te Herenga Waka-; Victoria University of Wellington's Ferrier Research Institute and the Malaghan Institute of Medical Research in New Zealand, and the Peter Doherty Institute for Infection and Immunity in Australia have developed an mRNA-based vaccine that can effectively target and stimulate protective immune cell responses against the malaria-causing parasite Plasmodium in preclinical models.
Source: news-medical.net
/cloudfront-ap-southeast-2.images.arcpublishing.com/nzme/IWHTSYRXAOPYQQ57YL623BX4PU.jpg)